This change will take effect May 17, 2012
Overview and Clinical Utility:
Because of their low sensitivity, enzyme immunoassay (EIA) tests are no longer recommended for detection of C. difficile toxin in stool specimens.1 Recent literature indicates that nucleic acid amplification-based assays provide sensitivities and specificities comparable to toxigenic culture, the current “gold standard” and provide significantly shorter turnaround times.
Click Here to read more.